WFG Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $12K | Sell |
150
-1,100
| -88% | -$88K | ﹤0.01% | 1094 |
|
|
2017
Q1 | $87K | Sell |
1,250
-300
| -19% | -$20.9K | 0.02% | 514 |
|
|
2016
Q4 | $92K | Sell |
1,550
-495
| -24% | -$29.4K | 0.02% | 545 |
|
|
2016
Q3 | $136K | Buy |
2,045
+1,820
| +809% | +$121K | 0.03% | 453 |
|
|
2016
Q2 | $12K | Hold |
225
| – | – | ﹤0.01% | 1052 |
|
|
2016
Q1 | $12K | Sell |
225
-747
| -77% | -$39.8K | ﹤0.01% | 1016 |
|
|
2015
Q4 | $68K | Sell |
972
-920
| -49% | -$64.4K | 0.02% | 572 |
|
|
2015
Q3 | $118K | Buy |
1,892
+14
| +0.7% | +$873 | 0.04% | 420 |
|
|
2015
Q2 | $158K | Buy |
1,878
+933
| +99% | +$78.5K | 0.04% | 406 |
|
|
2015
Q1 | $71K | Sell |
945
-1,485
| -61% | -$112K | 0.02% | 638 |
|
|
2014
Q4 | $151K | Sell |
2,430
-3,108
| -56% | -$193K | 0.03% | 519 |
|
|
2014
Q3 | $288K | Sell |
5,538
-1,896
| -26% | -$98.6K | 0.05% | 363 |
|
|
2014
Q2 | $382K | Sell |
7,434
-3
| -0% | -$154 | 0.07% | 313 |
|
|
2014
Q1 | $353K | Buy |
7,437
+3,201
| +76% | +$152K | 0.07% | 317 |
|
|
2013
Q4 | $184K | Buy |
4,236
+630
| +17% | +$27.4K | 0.03% | 542 |
|
|
2013
Q3 | $155K | Hold |
3,606
| – | – | 0.02% | 566 |
|
|
2013
Q2 | $125K | Buy |
+3,606
| New | +$125K | 0.02% | 587 |
|